12:00 AM
 | 
Aug 01, 2016
 |  BC Week In Review  |  Company News  |  Sales & Marketing

ANI Pharmaceuticals sales and marketing update

ANI launched a generic version of Nilandron nilutamide from Sanofi (Euronext:SAN; NYSE:SNY, Paris, France) in the U.S....

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >